[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fHqMDjNN_6RdU4pQBDhEOVYeB2V9l572pAb-HJVyIq8g":8,"$frmhvWvcpTzPAsb7Lq9Ugh-nwm0YU_cGNfyq1ivaZctw":55,"$fDJQqmuuqibr2-1bp_5jRZrV2U77Lq-bf816GlZsAC5c":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},69221,867218,[],"https://ystcdn.venuertc.com/medical/ystApp/PNv1JgZKMO3NbzWop7HvWPziztZOf4zJ.png","吕昭宝","聊城市第二人民医院","甲状腺乳腺外科","主治医师",183,0,"乳腺癌临床分期1的化疗方案：实用指导与解读","","https://ystcdn.venuertc.com/venue/AI/86a22af0-69a7-427e-846f-5dbef24d6086.jpg","\u003Cdiv id=\"material_title\" class=\"drugguide-title\">\n乳腺癌临床分期1的化疗方案：实用指导与解读\n\u003C/div>\n\n\u003Cdiv class=\"drugguide-section\">\n    \u003Cdiv class=\"drugguide-subtitle\">\n        说起乳腺癌的化疗，很多人最关心的就是用药方案、安全细节和服药经验。本文聚焦化疗常用药品（如紫杉醇脂质体、环磷酰胺）的正确用法、注意事项和可能风险，不谈疾病过程，只聊药品本身。你将了解到7个关键用药重点，实际案例也会结合说明。希望让每位读者都能明白用药，少走弯路。\n    \u003C/div>\n\u003C/div>\n\n\u003C!-- 01. 药品种类及作用机制 -->\n\u003Cdiv class=\"drugguide-section drugguide-bg1\">\n    \u003Cdiv class=\"drugguide-subtitle\">01&nbsp;常用化疗药品及其作用机制 🌸\u003C/div>\n    \u003Cdiv class=\"drugguide-content\">\n    分期1乳腺癌的化疗方案以抗肿瘤药为主，常见的有紫杉醇脂质体和环磷酰胺。\n    \u003Cul>\n        \u003Cli>\u003Cb>紫杉醇脂质体\u003C/b>是一种微管抑制剂，可阻断癌细胞分裂，主要通过稳定微管结构阻止细胞有丝分裂。脂质体包裹技术能减少药物对正常组织的损伤。\u003C/li>\n        \u003Cli>\u003Cb>环磷酰胺\u003C/b>属于烷化剂，通过破坏癌细胞DNA来抑制细胞增殖，对多种实体瘤有广泛应用。\u003C/li>\n    \u003C/ul>\n    化疗药品常搭配使用，既能增强疗效，也可能叠加部分副作用，合理选择和调整尤为重要。\n    \u003Cdiv class=\"drugguide-tip\">正确做法：了解化疗药品的机制后，更能配合医生指导科学用药。\u003C/div>\n    \u003Cdiv class=\"drugguide-data\">临床研究显示，紫杉醇类药物联合环磷酰胺治疗乳腺癌1期患者的有效率可达80%以上（Jones&nbsp;et al., 2005）。\u003C/div>\n    \u003C/div>\n\u003C/div>\n\n\u003C!-- 02. 剂型及服用技巧 -->\n\u003Cdiv class=\"drugguide-section drugguide-bg2\">\n    \u003Cdiv class=\"drugguide-subtitle\">02&nbsp;剂型及注射注意事项 🧴\u003C/div>\n    \u003Cdiv class=\"drugguide-content\">\n    紫杉醇脂质体和环磷酰胺均为注射剂，严格按照医院配置使用。两类药品需专业人员静脉滴注，普通人不可擅自操作。\n    \u003Cul>\n        \u003Cli>使用时应确保药液无异常色变、无沉淀。\u003C/li>\n        \u003Cli>滴注速度不能过快，以降低急性反应发生率。一般推荐1~3小时完成一次紫杉醇脂质体滴注。\u003C/li>\n        \u003Cli>部分药品如紫杉醇脂质体，对光敏感，滴注时建议遮光。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drugguide-tip\">服药技巧：治疗当天建议饮食清淡，避免油腻食物；注射过程中如出现不适，应及时告知护士。\u003C/div>\n    \u003C/div>\n\u003C/div>\n\n\u003C!-- 03. 服药时间与方案安排 -->\n\u003Cdiv class=\"drugguide-section drugguide-bg3\">\n    \u003Cdiv class=\"drugguide-subtitle\">03&nbsp;化疗时间和周期🌛\u003C/div>\n    \u003Cdiv class=\"drugguide-content\">\n    化疗药品的使用周期严格分配，过短易加重副作用，间隔过长则影响疗效。\n    \u003Cul>\n        \u003Cli>标准方案通常3周为一周期，每周期内按医生安排静脉注射一次或多次。\u003C/li>\n        \u003Cli>化疗前一天不建议自行服用解热镇痛药或近期接种疫苗，以免干扰药效。\u003C/li>\n        \u003Cli>部分患者在化疗后出现消化道反应，辅助止吐药可同步应用，多为静脉注射。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drugguide-tip\">正确做法：严格遵守医院制定的化疗时间，切勿随意缩短或延长间隔。\u003C/div>\n    \u003Cdiv class=\"drugguide-case\">有位58岁女性患者按三周一次方案完成三次化疗，仅在遵医嘱情况下使用辅助止吐药，未发生严重不良事件。\u003C/div>\n    \u003C/div>\n\u003C/div>\n\n\u003C!-- 04. 药物相互作用 -->\n\u003Cdiv class=\"drugguide-section drugguide-bg4\">\n    \u003Cdiv class=\"drugguide-subtitle\">04&nbsp;药物相互作用⚠️\u003C/div>\n    \u003Cdiv class=\"drugguide-content\">\n    紫杉醇脂质体和环磷酰胺与多种药物易发生相互作用，影响疗效或加重大副作用。\n    \u003Cul>\n        \u003Cli>不能与强抑制肝酶的药物（如酮康唑、伊曲康唑）同用，否则紫杉醇血药浓度升高。\u003C/li>\n        \u003Cli>环磷酰胺不宜与利福平合用，减少代谢，增加毒性风险。\u003C/li>\n        \u003Cli>部分辅助药（如生长因子、抗过敏药）需严格按配伍方案使用。\u003C/li>\n        \u003Cli>补充维生素类药品不影响药效，但切勿自行服用草药制品，以免不可控反应。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drugguide-tip\">特别提醒：所有新药品、保健品和传统草药，使用前须咨询主治医生或药师。\u003C/div>\n    \u003C/div>\n\u003C/div>\n\n\u003C!-- 05. 特殊人群用药调整 -->\n\u003Cdiv class=\"drugguide-section drugguide-bg5\">\n    \u003Cdiv class=\"drugguide-subtitle\">05&nbsp;特殊人群的用药调整 👩‍🦳\u003C/div>\n    \u003Cdiv class=\"drugguide-content\">\n    老年患者、肝肾功能受损者、孕哺乳期妇女用药方案需个体化。\n    \u003Cul>\n        \u003Cli>65岁以上患者应考虑从低剂量起步，药物清除速度较慢，侧重监测肝肾功能。\u003C/li>\n        \u003Cli>肝功能异常者不建议使用紫杉醇，换用其他方案；肾功不全者需减量使用环磷酰胺。\u003C/li>\n        \u003Cli>孕妇绝对禁用紫杉醇和环磷酰胺，哺乳期应暂停授乳。\u003C/li>\u003C/ul>\n    \u003C/div>\n\u003C/div>\n\n\u003C!-- 06. 常见不良反应及处理 -->\n\u003Cdiv class=\"drugguide-section drugguide-bg6\">\n    \u003Cdiv class=\"drugguide-subtitle\">06&nbsp;常见不良反应及处理方案 🚨\u003C/div>\n    \u003Cdiv class=\"drugguide-content\">\n    紫杉醇脂质体和环磷酰胺的主要副作用包括消化道反应、骨髓抑制、过敏反应、脱发等。\n    \u003Cul>\n        \u003Cli>消化道反应（恶心、呕吐）发生率约60%（Chollet et al., 2007）。辅助止吐药品如昂丹司琼可减轻症状。\u003C/li>\n        \u003Cli>骨髓抑制：出现白细胞或血小板减少时，需暂停化疗并根据血常规调整下次剂量。如有发热应立即就医。\u003C/li>\n        \u003Cli>过敏反应：紫杉醇在滴注前需预防性抗过敏药物注射，极个别患者可能发生过敏性休克。\u003C/li>\n        \u003Cli>脱发：化疗后常见，可佩戴假发改善外观，无需特殊处理。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drugguide-tip\">正确做法：出现异常不良反应及时报告医护人员，不要自行处理。\u003C/div>\n    \u003C/div>\n\u003C/div>\n\n\u003C!-- 07. 药品储存与有效期 -->\n\u003Cdiv class=\"drugguide-section drugguide-bg7\">\n    \u003Cdiv class=\"drugguide-subtitle\">07&nbsp;药品储存与管理 🗃️\u003C/div>\n    \u003Cdiv class=\"drugguide-content\">\n    化疗药品均为医院专用，仅在专业环境下贮存和分发，不应自行保管或携带。\n    \u003Cul>\n        \u003Cli>紫杉醇脂质体：需避光、2~8°C冷藏，开封后应当天用完。\u003C/li>\n        \u003Cli>环磷酰胺：避光、常温密封保存，吸湿易变质，开瓶后当天用完。\u003C/li>\n        \u003Cli>辅助用药止吐药多为片剂或注射剂，根据说明书保存于阴凉干燥处。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drugguide-tip\">特别提醒：剩余药品禁止自行保存，应交由护士处理，过期药品严禁使用。\u003C/div>\n    \u003C/div>\n\u003C/div>\n\n\u003C!-- 08. 漏药和过量处理 -->\n\u003Cdiv class=\"drugguide-section drugguide-bg8\">\n    \u003Cdiv class=\"drugguide-subtitle\">08&nbsp;漏服与过量应对措施 ⏳\u003C/div>\n    \u003Cdiv class=\"drugguide-content\">\n    虽然化疗药品均为医院注射，但有时因操作失误漏用或过量，需及时应对。\n    \u003Cul>\n        \u003Cli>漏用：下次药品给药时不宜补量，直接按常规剂量维持。\u003C/li>\n        \u003Cli>过量：短时过量可导致急性毒性反应（如严重骨髓抑制），需紧急就医，医院将给予支持性治疗。\u003C/li>\n        \u003Cli>自行额外服用止吐药时，如出现心悸或异常反应，需立刻停药并咨询医生。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drugguide-tip\">正确做法：任何用药异常及时向医护人员报告，不要自行调整化疗周期或剂量。\u003C/div>\n    \u003C/div>\n\u003C/div>\n\n\u003C!-- 09. 用药案例分享 -->\n\u003Cdiv class=\"drugguide-section drugguide-bg9\">\n    \u003Cdiv class=\"drugguide-subtitle\">09&nbsp;临床用药小案例 📋\u003C/div>\n    \u003Cdiv class=\"drugguide-content\">\n    \u003Cul>\n        \u003Cli>一位58岁女性连续三次化疗，每次使用紫杉醇脂质体+环磷酰胺，按周期注射，配合止吐药辅助，有效减轻不良反应。\u003C/li>\n        \u003Cli>临床上部分老年患者化疗时调整剂量，同时监测肝肾功能，有助于降低风险。\u003C/li>\n        \u003Cli>有患者化疗间期服用保健品出现异常，需要停用所有保健品、补充维生素须经医生确认。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drugguide-tip\">案例经验显示，遵循医生指导，规范用药周期，不随意加药减药，是减少副作用和保证疗效的关键。\u003C/div>\n    \u003C/div>\n\u003C/div>\n\n\u003C!-- 10. 实用总结与安全提醒 -->\n\u003Cdiv class=\"drugguide-section drugguide-bg10\">\n    \u003Cdiv class=\"drugguide-subtitle\">10&nbsp;实用总结与终极安全提示 🛡️\u003C/div>\n    \u003Cdiv class=\"drugguide-content\">\n    \u003Cul>\n        \u003Cli>紫杉醇脂质体和环磷酰胺需医院专业注射，自行调整周期或剂量风险极高。\u003C/li>\n        \u003Cli>用药期间注意饮食清淡，异常不适及时报告护士。\u003C/li>\n        \u003Cli>所有新药品、保健品、草药须提前告知医生，不可自行增减。\u003C/li>\n        \u003Cli>肝肾功能异常、孕哺乳期妇女须严格避用或个体调整。\u003C/li>\n        \u003Cli>不良反应发生率高，配合应用止吐药、抗过敏药可减轻副作用。\u003C/li>\n        \u003Cli>药品储存严格依照说明，剩余药品切勿自行处理。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drugguide-summary\">\n        紫杉醇脂质体和环磷酰胺是乳腺癌1期常用化疗药，安全用药要点在于周期规范、剂量合理、及时监测，特殊人群严格调整。希望以上药品知识能帮助大家谨慎用药，减少风险。如果遇到不良反应或用药困惑，请随时咨询专业医护人员。\n    \u003C/div>\n    \u003C/div>\n\u003C/div>\n\n\u003C!-- 文献引用 -->\n\u003Cdiv class=\"drugguide-section drugguide-bg11\">\n    \u003Cdiv class=\"drugguide-subtitle\">🔖 参考文献\u003C/div>\n    \u003Cdiv class=\"drugguide-content\">\n        \u003Col>\n            \u003Cli>Jones, S.E., Erban, J., Overmoyer, B., Budd, G.T., Hutchins, L., Lower, E., ... &amp; McIntyre, K. (2005). \"Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer.\" \u003Ci>Journal of Clinical Oncology, 23(24)\u003C/i>, 5542-5551. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/16135480/\" target=\"_blank\">(PubMed)\u003C/a>\u003C/li>\n            \u003Cli>Chollet, P., Amey, S., Cure, H., Genet, D., Valette, F., Largeau, J., ... &amp; Ferrer, J. (2007). \"Safety and efficacy data of weekly taxane-based chemotherapy for early-stage breast cancer.\" \u003Ci>Breast Cancer Research and Treatment, 105(1)\u003C/i>, 59-65. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/17211675/\" target=\"_blank\">(PubMed)\u003C/a>\u003C/li>\n        \u003C/ol>\n    \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.drugguide-title {\n    font-size: 38px;\n    font-weight: bold;\n    text-align: center;\n    color: #314876;\n    margin-top: 30px;\n    margin-bottom: 30px;\n    letter-spacing: 2px;\n}\n.drugguide-section {\n    max-width: 830px;\n    margin: 24px auto;\n    padding: 28px 42px 30px 42px;\n    border-radius: 16px;\n    box-shadow: 0 2px 16px 0 rgba(62,84,158,0.09);\n    background: #fcfa;\n}\n.drugguide-subtitle {\n    font-size: 27px;\n    font-weight: 600;\n    margin-bottom: 16px;\n    color: #215076;\n    letter-spacing: 1.5px;\n    padding: 14px 0;\n    text-align: left;\n    background: linear-gradient(90deg, #e3edf4 0%, #f9fafc 100%);\n    border-left: 8px solid #b3d1f8;\n    border-radius: 8px;\n}\n.drugguide-content {\n    font-size: 17px;\n    line-height: 2;\n    color: #354659;\n    margin-top: 10px;\n}\n\n.drugguide-tip {\n    font-size: 16px;\n    color: #1f7c70;\n    padding: 11px 16px;\n    background: linear-gradient(90deg, #e9f7fa 0%, #f7fc 100%);\n    border-left: 5px solid #8fdfda;\n    margin: 12px 0;\n    border-radius: 6px;\n}\n\n.drugguide-data {\n    font-size: 15px;\n    color: #a8552e;\n    background: #fff5ee;\n    padding: 8px 14px;\n    border-left: 4px solid #faebd7;\n    border-radius: 5px;\n    margin-top: 10px;\n}\n\n.drugguide-case {\n    font-size: 15px;\n    color: #466fb6;\n    background: #f6f8fa;\n    border-left: 4px solid #b0cbe9;\n    padding: 8px 14px;\n    border-radius: 5px;\n    margin-top: 10px;\n}\n\n.drugguide-summary {\n    font-size: 18px;\n    color: #324864;\n    font-weight: 500;\n    background: #f5f9fc;\n    padding: 15px 20px;\n    border-radius: 8px;\n    margin-top: 20px;\n    letter-spacing: 0.5px;\n}\n\n.drugguide-bg1   { background: linear-gradient(90deg, #ecf4fa 0%, #f8fafd 100%) !important; }\n.drugguide-bg2   { background: linear-gradient(90deg, #f5f7fa 0%, #e9eef3 100%) !important; }\n.drugguide-bg3   { background: linear-gradient(90deg, #f8fcfa 0%, #f5eefc 100%) !important; }\n.drugguide-bg4   { background: linear-gradient(90deg, #f6f8fa 0%, #eaf1fb 100%) !important; }\n.drugguide-bg5   { background: linear-gradient(90deg, #f8faf6 0%, #eaf4f4 100%) !important; }\n.drugguide-bg6   { background: linear-gradient(90deg, #fcfaf8 0%, #f4eaf8 100%) !important; }\n.drugguide-bg7   { background: linear-gradient(90deg, #f8fafc 0%, #eaf1fb 100%) !important; }\n.drugguide-bg8   { background: linear-gradient(90deg, #fdfaf8 0%, #f1f5ee 100%) !important; }\n.drugguide-bg9   { background: linear-gradient(90deg, #faf8fc 0%, #eaf4fb 100%) !important; }\n.drugguide-bg10  { background: linear-gradient(90deg, #f6faf8 0%, #eaf1fa 100%) !important; }\n.drugguide-bg11  { background: linear-gradient(90deg, #f8f9fa 0%, #f5fc 100%) !important; }\n\n@media (max-width: 600px) {\n    .drugguide-section { padding: 10px 8px; }\n    .drugguide-title { font-size: 25px; margin-top: 14px; margin-bottom: 20px; }\n    .drugguide-subtitle { font-size: 18px; padding: 9px 0; }\n    .drugguide-content { font-size: 15px; }\n    .drugguide-tip, .drugguide-case, .drugguide-data { font-size: 13px; padding: 7px 10px; }\n}\n\u003C/style>","\u003Cdiv id=\"material_title\" class=\"drugguide-title\">\n乳腺癌临床分期1的化疗方案：实用指导与解读\n\u003C/div>\n\n\u003Cdiv class=\"drugguid",298,"2025-10-31 00:05:32","乳腺癌, 化疗方案, 紫杉醇脂质体, 环磷酰胺, 不良反应, 用药经验, 安全用药, 化疗周期","了解乳腺癌1期化疗的关键药品、用药机制及常见副作用，助患者科学用药，安全度过治疗期，及时调整方案，以实现最佳疗效。","2025-11-18 16:01:07",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]